Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Aperam (APEMY) had Non-Operating Income/Expense of $-102.96M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.88B |
|
$10.18M |
|
$6.50B |
|
$383.54M |
|
$6.86B |
|
$18.10M |
|
|
Non-Operating Income/Expense |
$-102.96M |
$-84.86M |
|
$-83.72M |
|
$11.31M |
|
$11.31M |
|
$11.31M |
|
$13.73M |
|
$18.10M |
|
$311.13M |
|
72.32M |
|
73.07M |
|
$0.15 |
|
$0.15 |
|
| Balance Sheet Financials | |
$2.19B |
|
$2.52B |
|
$3.66B |
|
$5.85B |
|
$695.81M |
|
$1.21B |
|
$1.53B |
|
$2.22B |
|
-- |
|
$3.06B |
|
$3.63B |
|
-- |
|
| Cash Flow Statement Financials | |
$477.45M |
|
$-666.39M |
|
$315.66M |
|
-- |
|
-- |
|
$123.32M |
|
-- |
|
$-164.05M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|